IFN-treatment of B16-F1 versus B16-F10: Relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread
- 1 September 1988
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 6 (5) , 411-429
- https://doi.org/10.1007/bf01760576
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferonCell, 1985
- Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfectionNature, 1985
- Biologicals and Biological Response Modifiers: New Approaches to Cancer TreatmentCancer Investigation, 1985
- Biological Response Modifiers: Their Potential and Limitations in Cancer TherapeuticsCancer Investigation, 1985
- Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cellsNature, 1984
- The effect of gamma-interferon on MHC antigensImmunology Today, 1984
- HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.Journal of Clinical Investigation, 1984
- The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptorsCellular Immunology, 1983
- A Rapid Method for the Separation of Functional Lymphoid Cell Populations of Human and Animal Origin on PVP‐Silica (Percoll) Density GradientsScandinavian Journal of Immunology, 1979
- Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.The Journal of Experimental Medicine, 1978